EXHIBIT 16.1

November 3, 2020

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549  

RE: Nutralife Biosciences, Inc. Changes in Registrant’s Certifying Accountant  

We have read the statements of Nutralife Biosciences, Inc., pertaining to our firm included under Item 4.01 of Form 8-K dated November 3, 2020 and agree with such statements as they pertain to our firm. We have read Item 4.01, captioned “Changes in Registrant’s Certifying Accountant,” of the Current Report on Form 8-K of Nutralife Biosciences, Inc., and are in agreement with the statements therein as they relate to our firm. We have no basis to agree or disagree with the other statements contained therein.

  Sincerely,

/s/ Daszkal Bolton LLP

Certified Public Accountants

Fort Lauderdale, Florida